US Patent 8124066 Methods of using interleukin-2 mutants with reduced toxicity
Patent 8124066 was granted and assigned to University of Southern California on February, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8124066 Methods of using interleukin-2 mutants with reduced toxicity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.